Retaglutide and tirzepatide are newer GLP-1 receptor agonists gaining attention as effective treatment options for type 2 diabetes. These medications promote insulin secretion from the pancreas, suppress glucagon https://kiaraadwl564533.wikiannouncement.com/9664469/emerging_therapies_for_type_2_diabetes